You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
BC 11 hydrobromide
Biological Activity for BC 11 hydrobromide
BC 11 hydrobromide is a selective urokinase (uPA) inhibitor (IC50 = 8.2 μM). Exhibits no activity at 8 other related enzymes. Inhibits clot lysis with no effect on clot formation. Also decreases viability of MDA-MB231 breast cancer cells in vitro.
Technical Data for BC 11 hydrobromide
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for BC 11 hydrobromide
|Solvent||Max Conc. mg/mL||Max Conc. mM|
|water||5.82||20 with gentle warming|
Preparing Stock Solutions for BC 11 hydrobromide
The following data is based on the product molecular weight 290.97. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||3.44 mL||17.18 mL||34.37 mL|
|5 mM||0.69 mL||3.44 mL||6.87 mL|
|10 mM||0.34 mL||1.72 mL||3.44 mL|
|50 mM||0.07 mL||0.34 mL||0.69 mL|
Product Datasheets for BC 11 hydrobromide
References for BC 11 hydrobromide
References are publications that support the biological activity of the product.
Smith et al (2011) Elucidating novel urokinase-type plasminogen activator inhibitors. Int.Soc.Thromb.Haemost. (Abstract) 9 819
Longo et al (2015) Cytotoxicity of the Urokinase-Plasminogen Activator Inhibitor Carbamimidothioic Acid (4-Boronophenyl) Methyl Ester Hydrobromide (BC-11) on Triple-Negative MDA-MB231 Breast Cancer Cells Molecules 20 9879 PMID: 26029857
If you know of a relevant reference for BC 11 hydrobromide, please let us know.
View Related Products by Product Action
Keywords: BC 11 hydrobromide, BC 11 hydrobromide supplier, BC11, HBr, urokinase, inhibitor, inhibits, uPA, urokinase-type, plasminogen-activator, inhibitors, Urokinase, 4372, Tocris Bioscience
3 Citations for BC 11 hydrobromide
Citations are publications that use Tocris products. Selected citations for BC 11 hydrobromide include:
Semina et al (2016) Urokinase and urok. receptor participate in regulation of neuronal migration, axon growth and branching. Eur.J.Cell Biol. 95 295 PMID: 27324124
Keasey et al (2018) Blood vitronectin is a major activator of LIF and IL-6 in the brain through integrin-FAK and uPAR signaling. J Cell Sci 131 PMID: 29222114
Magnussen et al (2017) Cleavage of the urok. receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion. BMC Cancer 17 350 PMID: 28526008
Do you know of a great paper that uses BC 11 hydrobromide from Tocris? Please let us know.
Reviews for BC 11 hydrobromide
Average Rating: 4 (Based on 1 Review.)
Have you used BC 11 hydrobromide?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.